ReviewNpj gut and liver2026
Single-cell insights into hepatic fibroblasts and stellate cells: heterogeneity in matrix remodelling in development, health, and disease.
Review in Npj gut and liver, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Hepatic fibroblasts and hepatic stellate cells (HSCs) are dynamic regulators of liver development, homeostasis, and disease beyond structural roles. Advances in single-cell transcriptomics have provided new evidence on their heterogeneity, plasticity, and diverse functions across developmental and pathological contexts. This review synthesises contribution from single-cell and single-nuclei RNA sequencing studies to the understanding of the ontogeny, transcriptional diversity, and roles of hepatic stromal populations in foetal and adult liver. We highlight distinct fibroblast and HSC subpopulations identified across development and disease, characterised by extracellular matrix programmes and markers associated with shaping the hepatic microenvironment. We further examine their activation in chronic liver disease and reprogramming into cancer-associated fibroblasts in hepatobiliary cancers, and discuss how single-cell approaches are contributing to the re-evaluation of stromal plasticity by revealing cell-state transitions and informing in vitro modelling and targeted therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.